/newsroom/taxonomy/term/6805/all en /newsroom/channels/news/new-drug-molecule-could-lead-new-treatments-parkinsons-disease-younger-patients-359804 <p>A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research.</p> <p>“We are excited about this drug compound because we might have the possibility to develop the first cure for Parkinson’s disease, at least for a subset of patients,” said lead author <a href="/newsroom/kalle-gehring">Kalle Gehring</a>, a Professor in the Department of Biochemistry at ƽ���岻�� and Canada Research Chair in Structural Studies of Neurodegenerative Diseases.</p> Fri, 20 Sep 2024 13:37:21 +0000 keila.depape@mcgill.ca 314637 at /newsroom /newsroom/channels/news/progression-parkinsons-disease-follows-brain-connectivity-283808 <p>A study by a group of researchers including those from The Montreal Neurological Institute and Hospital of ƽ���岻�� has tested the theory that brain degeneration in Parkinson’s disease (PD) originates in subcortical regions and spreads along neural networks to the cerebral cortex. By analyzing data on PD patients and healthy controls collected over one year, the researchers found that brain regions closely connected to subcortical regions showed the most degeneration over the one-year period in PD patients, and that this happens earlier than previously thought.</p> Thu, 11 Jan 2018 15:37:18 +0000 mona.noonoo@mail.mcgill.ca 32826 at /newsroom /newsroom/channels/news/parkinsons-disease-new-tool-diagnosis-256723 <p><span>The results of their study, published in the journal </span><em>Movement Disorders</em><span>, could also have a major impact on the quality of research on Parkinson’s disease.</span></p> Fri, 13 Nov 2015 15:34:15 +0000 nima.adibpour@mail.mcgill.ca 24722 at /newsroom